News from moderna therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 01, 2014, 08:00 ET

Moderna Appoints Oncology Leader Dr. Stephen Kelsey as President of Onkaido

 Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics™, a revolutionary treatment modality to enable the in...

Jun 17, 2014, 13:28 ET

Moderna Named to CNBC Disruptor 50 List

 Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics™, today announced it was named to the 2014 CNBC...

Jun 12, 2014, 08:00 ET
Moderna Therapeutics, the pioneer in developing messenger RNA Therapeutics(TM), expanded its headquarters, including laboratories, Moderna Venture Incubator and manufacturing, on June 11, 2014 to 320 Bent St. in Cambridge, Mass. Pictured from left to right: Stephane Bancel, President and founding CEO, Moderna Therapeutics; Angus McQuilken, Vice President, Massachusetts Life Sciences Center; John Hallinan, Chief Business Officer, MassBio; Noubar Afeyan, Co-founder and Chairman, Moderna Therapeutics, Managing Partner and CEO, Flagship Ventures. (PRNewsFoto/Moderna Therapeutics)

Moderna Announces Expansion to New Facility in Kendall Square

 Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics™, is announcing the company's expansion to 320 Bent...

May 21, 2014, 08:00 ET

Moderna Forms Technology Advisory Board to Provide Expertise for the Company's GMP Manufacturing Strategy

 Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics™, a revolutionary treatment modality to enable the in...

Mar 06, 2014, 08:00 ET

Moderna Appoints Biotechnology Investment Banking Veteran Lorence Kim as Chief Financial Officer

 Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics™, a revolutionary treatment modality to enable the in...

Jan 14, 2014, 11:30 ET

Moderna Launches Onkaido Therapeutics to Focus on the Development of mRNA Therapeutics™ in Oncology with $20 Million Capital Commitment

 Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics™, a revolutionary treatment modality to enable the in...

Jan 06, 2014, 08:00 ET

Moderna Therapeutics to Present at 32nd Annual J.P. Morgan Healthcare Conference

 Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics™, a revolutionary new treatment modality to enable the...

Dec 17, 2013, 08:00 ET

Moderna Therapeutics Appoints Theo Melas-Kyriazi to Board of Directors

 Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics™, a revolutionary new treatment modality to enable the...

Nov 20, 2013, 08:30 ET

Moderna Therapeutics Announces New Equity Financing, Raising $110M to Develop messenger RNA Therapeutics™

 Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics™, a revolutionary new treatment modality to enable the...

Oct 24, 2013, 08:00 ET

Moderna Therapeutics Named to the World Economic Forum's Community of "Global Growth Companies"

 Moderna Therapeutics, the pioneering company developing messenger RNA (mRNA) therapeutics™, a revolutionary new treatment modality to...

Oct 17, 2013, 08:00 ET
From Left to Right: Tim Toomey, Massachusetts State Representative, Cambridge; Noubar Afeyan, Co-founder and Chairman, Moderna; Managing Partner & CEO, Flagship Ventures; Stephane Bancel, President and Founding CEO, Moderna; Angus McQuilken, Vice President for Communications & Marketing, Massachusetts Life Sciences Center.  (PRNewsFoto/Moderna Therapeutics)

Moderna Therapeutics Announces Expansion to New Headquarters and Laboratories at 200 Tech Square

Moderna Therapeutics, the pioneering company developing messenger RNA therapeutics™, a revolutionary new treatment modality to enable the in...

Oct 02, 2013, 08:00 ET

DARPA Awards Moderna Therapeutics A Grant For Up To $25 Million To Develop Messenger RNA Therapeutics™

 Moderna Therapeutics, the company pioneering messenger RNA therapeutics™, a revolutionary new treatment modality to enable the in vivo...

Sep 24, 2013, 07:00 ET

Moderna Therapeutics Named a "Fierce 15" Biotech Company for 2013

Moderna Therapeutics, the pioneering company developing messenger RNA therapeutics™, a revolutionary new treatment modality to enable the in...

Sep 08, 2013, 13:00 ET

Study Published in Nature Biotechnology Demonstrates Ability of Moderna's Novel Therapeutic Paradigm to Repair and Regenerate Damaged Heart Tissue

 Moderna Therapeutics, the pioneering company developing messenger RNA therapeutics™, a revolutionary new treatment modality to enable...

Jul 31, 2013, 07:30 ET

Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development

Moderna Therapeutics, the pioneering company developing messenger RNA therapeutics™, a revolutionary new treatment modality to enable the in...

May 22, 2013, 07:30 ET

Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer

 Moderna Therapeutics, the pioneering company developing messenger RNA therapeutics™, a revolutionary new treatment modality to enable...

Apr 30, 2013, 07:30 ET

Henri A. Termeer Joins Moderna Therapeutics Board Of Directors

Moderna Therapeutics, the pioneering company developing messenger RNA therapeutics™—a revolutionary new treatment modality to enable...

Jan 16, 2013, 07:30 ET

-- Moderna Appoints Divakar Ramakrishnan, Ph.D., As Senior Vice President Of Process Development, Manufacturing And Quality --

 Moderna Therapeutics, which is developing a new platform designed to spur the body to create its own therapeutic proteins to treat a wide...

Dec 19, 2012, 07:30 ET

Moderna Therapeutics Announces Appointment Of Stephen Hoge, MD As Senior Vice President Of Corporate Development And New Drug Concepts

Moderna Therapeutics, which is developing a new platform designed to spur the body to create its own therapeutic proteins to treat a wide range of...

Dec 06, 2012, 00:01 ET

Moderna annonce un financement de 40 millions de dollars pour faire avancer le développement d'une nouvelle modalité de traitement biothérapeutique : messenger RNA Therapeutics™

-La société annonce la nomination d'une équipe de direction et d'un conseil consultatif scientifique Moderna Therapeutics annonce...